Skip to content

Comparision of 2 drugs (bupivacaine and levobupivacaine) in spinal anaesthesia for planned caesarean delivery.

Comparison of Intrathecal Hyperbaric Levobupivacaine with Hyperbaric Bupivacaine for Lower Segment Caesarean Section: A Randomized Double-blind Comparative Study. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058741
Enrollment
60
Registered
2023-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Levobupivacaine vs Bupivacaine: Comparison of intrathecal hyperbaric levobupivacaine (0.5%) -2ml and hyperbaric bupivacaine (0.5%) -2ml in lower segment caesarean section for 1 year Con

Sponsors

Rabindranath Tagore Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age 18-40 years old, ASA physical status II (uncomplicated pregnancy comes in ASA II), Full term parturients scheduled for elective and semielective LSCS under spinal anaesthesia for indications like previous LSCS, primi breech, postdatism, cord around neck, cephalopelvic disproportion, non progress of labour. Height 150-170 cm, weight 45-90kg.

Exclusion criteria

Exclusion criteria: Patient refusal. Patient with contraindication to spinal anaesthesia like coagulopathies or anticoagulant medication, raised intracranial pressure, local puncture site infection etc. Any cardiac, neurological, renal, liver, endocrine, hematological or any coexisting systemic medical comorbidity, short stature, obesity (BMI more than 30 kg/m2). Difficult airway, anticipated difficult spinal kyphocoliosis, obese, prior spine surgery. Emergency LSCS. Any obstetric comorbidity like antepartum hemorrhage, gestational diabetes etc. History of allergy to study drugs.

Design outcomes

Primary

MeasureTime frame
Duration of sensory blockadeTimepoint: Upto 3 hours postoperatively

Secondary

MeasureTime frame
Intraoperative hemodynamics & side effects.Timepoint: upto 24 hours postoperatively.

Countries

India

Contacts

Public ContactDr Gaurav Saxena

RNT Medical College

uditanaithani@gmail.com9829414752

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026